A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
Trial details
- Registry ID
- NCT06915233
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the AnkleNCT06915233 | Vericel Corporation | Phase 3 | Recruiting | 2030-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |